Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Calfactant - Ony

Drug Profile

Calfactant - Ony

Alternative Names: Infasurf

Latest Information Update: 18 Mar 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ony
  • Developer Allergan; Ony
  • Class Phospholipids; Pulmonary surfactants
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Adult respiratory distress syndrome
  • New Molecular Entity No

Highest Development Phases

  • Marketed Neonatal respiratory distress syndrome
  • Phase I Bronchitis
  • No development reported Acute lung injury
  • Discontinued Adult respiratory distress syndrome

Most Recent Events

  • 12 Jan 2019 Phase-I clinical trials in Bronchitis (In infants, In neonates) in USA (Inhalation) (NCT03748173)
  • 23 Nov 2018 Ony plans the phase I Aero-04 trial in Bronchiolitis (In neonates, In infants) in December 2018 (NCT03748173)
  • 31 Jul 2018 ONY completes a phase III trial in Respiratory distress syndrome (In neonates) in USA (Inhalation, Aerosol) (NCT03058666)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top